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Abstract
Bone marrow-derived multi-potent stromal cells (MSCs) offer great promise for regenerating tissue.
While certain transcription factors have been identified in association with tendency toward particular
MSC differentiation phenotypes, the regulatory network of key receptor-mediated signaling
pathways activated by extracellular ligands that induce various differentiation responses remain
poorly understood. Attempts to predict differentiation fate tendencies from individual pathways in
isolation are problematic due to the complex pathway interactions inherent in signaling networks.
Accordingly, we have undertaken a multi-variate systems approach integrating experimental
measurement of multiple kinase pathway activities and osteogenic differentiation in MSCs, together
with computational analysis to elucidate quantitative combinations of kinase signals predictive of
cell behavior across diverse contexts. In particular, for culture on polymeric biomaterials surfaces
presenting tethered epidermal growth factor (tEGF), type-I collagen, neither, or both, we have found
that a partial least-squares regression model yields successful prediction of phenotypic behavior on
the basis of two principal components comprising the weighted sums of 8 intracellular
phosphoproteins: p-EGFR, p-Akt, p-ERK1/2, p-Hsp27, p-c-jun, p-GSK3α/β, p-p38, and p-STAT3.
This combination provides strongest predictive capability for 21-day differentiated phenotype status
when calculated from day-7 signal measurements (99%); day-4 (88%) and day-14 (89%) signal
measurements are also significantly predictive, indicating a broad time-frame during MSC
osteogenesis wherein multiple pathways and states of the kinase signaling network are quantitatively
integrated to regulate gene expression, cell processes, and ultimately, cell fate.
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INTRODUCTION
Bone marrow-derived multi-potent stromal cells (MSCs) are versatile progenitor cells capable
of differentiating into bone, cartilage, and fat cells1–3 with potential for regenerative medicine
applications. Epidermal growth factor receptor (EGFR)-mediated signaling has been
implicated in many steps of MSC proliferation and bone regeneration4–7. We have previously
shown that tethering EGF to polymeric substrates to physically inhibit endocytosis of the EGF-
EGFR complex elicits sustained EGFR activity8, 9 and increased osteogenic differentiation of
MSCs compared to control surfaces when induced by osteogenic media10. Activation of EGFR
is also associated with enhanced proliferation of the stem or progenitor cell compartment
without impairing differentiation4, 7, or even enhancing differentiation under osteogenic
conditions5, but elucidation of the signaling networks linking EGFR to bone differentiation is
incomplete. In fact, many signals downstream of EGFR are contested in literature regarding
their positive or negative influences on MSC osteogenic differentiation. Both inhibition and
activation of ERK and MAPK signaling have been shown to increase osteogenesis in MSCs
and pre-osteoblasts11–13. Conflict around PI3K/Akt, another major signaling molecule and
pathway which may be preferentially activated by tEGF restricting EGFR signaling to the
plasma membrane14, 15, includes reports showing that activation16–19 and inhibition5 increase
osteogenic differentiation. GSK3α/β and p38 MAPK interact with MAPK and PI3K pathways,
both positively and negatively, to inhibit or activate Runx2, the master osteogenic transcription
factor – further confounding the total picture20–25 of an individual pathway’s effect on
osteogenic differentiation.
These disputed effects may arise from univariate examination of progenitor cell differentiation
signals especially since these pathways integrate at the level of activation of ubiquitous kinases
such as ERK, Akt, JNK, STAT, p38, and GSK3α/β (Supplementary Fig 1), which participate
in osteogenic differentiation programs, activated by various ligands, soluble factors, and cues.
MSCs must integrate multiple cues from the microenvironment and neighboring cells to make
decisions about differentiation and proliferation. Computational analysis of the dynamic
changes in kinase activation has shown that kinases act as integrators of cue information to
produce specific cellular responses26, 27. Importantly, prediction of cell phenotypic behavior
across diverse contexts and treatment conditions is substantially improved when multiple
pathways are considered in concert, rather than any single particular signaling pathway. In such
studies, systematic variation of extracellular cues across a landscape of conditions allows a
broad range of signaling network activities to be considered.
Herein we accordingly employ a multi-variate, quantitative systems approach to understand
how various kinase pathways work together to govern osteogenic differentiation of MSCs
across a number of biomaterial conditions, examining outcomes from culture on polymeric
substrates presenting tEGF and/or Collagen-I. Our signaling measurements target kinases
previously implicated either in differentiation or proliferation and known to be activated by a
spectrum of stimuli: EGFR (Tyr)4, 5, 7, 28–32, ERK1/2 (Thr202/Tyr204, Thr185/Tyr187)11,
13, 19, 33–37, Akt (Ser473)16, 17, 19, p38 MAPK (Thr180/Tyr182)13, 22, 23, 38–41, HSP27
(Ser78)42, c-Jun (Ser63)43–45, STAT3 (Ser727)46, and GSK3α/β (Ser21/Ser9) 20, 21, 25,
47, 48. Signals were measured after 1, 2, 4, 7, and 14 days of culture, and analyzed with respect
to their predictive relationships to 21 day matrix mineralization, a marker of osteogenic
differentiation, across all the diverse culture conditions.
Computational analysis was undertaken using partial least squares regression (PLSR), a data-
driven modeling technique proven in previous work in other cell phenotypic fate decision
studies to ascertain quantitative contributions of multiple signals to a measured cellular
response26, 27. The PLSR model relates cellular kinase signals across multiple pathways
(specifically: ERK, Akt, p38, JNK, GSK3, and STAT3) to 21-day matrix mineralization. We
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find not only that a kinase ‘network signature’ quantitatively combining seven phospho-site
levels on day 7 from this set of pathways successfully accounts for tEGF effects on day 21
mineralization, but also successfully predicts a priori both of two opposing effects of using
adsorbed Collagen-I as a substrate for MSC culture relative to nonspecific adhesion: an increase
in mineralization in the absence of tEGF, and a decrease in mineralization in the presence of
tEGF. This latter finding addresses the challenge of extrapolating outcomes from individual
cues/conditions to complex in vivo situations, demonstrating the utility of network signatures
that integrate diverse inputs to provide predictive information.
MATERIALS AND METHODS
Cell culture
Primary human multi-potent stromal cells were obtained from Tulane Center for Gene Therapy,
and maintained according to prescribed protocols. MSCs were expanded in α-MEM with L-
glutamine and without ribonucleosides or deoxyribonucleosides (Invitrogen/GIBCO)
supplemented with 16.5% fetal bovine serum (Atlanta Biologicals), L-glutamine (200 mM),
and penicillin-streptomycin (100 units/ml -100 µg/ml). For osteogenic differentiation, medium
was supplemented with 50 µM L-Ascorbic acid 2-phosphate, 20 mM β-glycerophosphate, and
10 nM dexamethasone.
Polymeric substrate preparation
Polymeric substrates were prepared as previously described8 with one modification; control
surfaces were prepared with the same 40:60 tEGF-polymer:diluent ratio as the tEGF surfaces,
but phosphate buffer without EGF was used during the coupling procedure. For in vitro
experiments, each substrate was placed in individual wells of a 12-well plate and seeded with
~25,000 cells/cm2 (50,000 cells per well). After the culture period and treatments, prior to
biochemical assay, surfaces were transferred to a new 12 well plate. Where indicated, substrates
were coated with rat tail collagen I (BD Biosciences) in phosphate buffered saline by incubation
in 1 µg/ml solution for one hour at room temperature, followed by 3 rinses in sterile phosphate
buffered saline prior to biochemical assay.
Cell and protein quantification
Cell counts were determined using the CyQuant DNA assay (Invitrogen) according to
manufacturer protocols. Total protein concentrations were determined using the BCA kit
(Pierce).
Immunoassays for quantifying signaling protein phosphorylation
Bioplex® bead kits were used for phosphorylated EGFR determination (BioRad), and
Novagen® bead kits were used for total EGFR determination (EMD Sciences) according to
manufacturer’s instructions with 10 µg protein from each sample. Bioplex assays were
conducted for the following kinases: EGFR (Tyr)4, 5, 7, 28–32, ERK1/2 (Thr202/Tyr204,
Thr185/Tyr187)11, 13, 19, 33–37, Akt (Ser473)16, 17, 19, p38 MAPK (Thr180/Tyr182)13,
22, 23, 38–41, HSP27 (Ser78)42, c-Jun (Ser63)43–45, STAT3 (Ser727)46, and GSK3α/β
(Ser21/Ser9) 20, 21, 25, 47, 48. Signals were measured after 1, 2, 4, 7, and 14 days of culture.
EGFR fluorescence values at each point were used to calculate absolute EGFR numbers using
a standard curve generated with increasing concentrations of the extracellular domain of EGFR
provided by the manufacturer (Novagen). Signal values for each different phosphorylated
kinase were normalized to the value for that kinase in a master lysate prepared in bulk from
MSCs stimulated with 1 ng/ml soluble EGF and exposed to UV for 30 minutes to activate
different kinase pathways, separated into single thaw aliquots, and used with each experiment.
Platt et al. Page 3
Stem Cells. Author manuscript; available in PMC 2010 November 9.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Signal values for each different kinase were then divided by the maximum value observed for
that kinase over the entire experimental time period, thus scaling values between 0 and 1.
Statistical testing
Significance was determined using unpaired student’s t-test. P values <0.05 were considered
significantly different.
Partial Least-Squares Regression modeling
Raw data values from Bioplex analysis were first normalized to the master lysate (i.e., the time
course data set for each kinase in the samples was divided by the reference value for that kinase
in the master lysate). Resulting normalized values for each kinase were then normalized to the
maximum value in the time course data set for that kinase, thus scaling all values between 0
and 1. This process was also used for the alkaline phosphatase activity assay, all quantitative
RT-PCR, cell proliferation, and xMAP assays. To generate the PLSR model, SIMCA-P
software (UMetrics) was used as described previously49; a detailed explanation of the approach
is provided in the Supplementary Materials.
RESULTS
Tethered EGF influences cell proliferation and differentiation
In the context of regenerative medicine applications, proliferation and expansion of adult stem
cells will be an important aspect prior to terminal differentiation. We have previously found
that tEGF acts to enhance osteogenic differentiation of these MSCs10 (Fig 1A), so broadened
our assessment of tEGF effects by measuring increases in cell number for both undifferentiating
and differentiating MSCs on tEGF or control surfaces (Fig 1B). MSCs were seeded onto 12-
mm control or tEGF surfaces at a density of 25,000 cells/cm2. MSCs were cultured in either
expansion medium (Exp), which maintains the cells in an undifferentiated phenotype, or with
osteoinductive supplements (OS) added 24 hours after seeding. There were a greater number
of cells after 7 days in Exp medium compared to OS medium, and tEGF induced greater
proliferation (Fig 1B; *p<0.05). Increases in MSC cell number halted in OS medium between
7 and 14 days of culture at cell confluence, but continued to increase through day 21 in Exp
medium resulting in overlapping cell layers. By day 21, tEGF and control cell numbers were
the same within a medium condition, perhaps due to contact inhibition of cell division.
Kinase signaling data-compendium reveals complex multi-pathway activities during
osteogenic differentiation
To investigate how key signaling pathways govern the phenotypic behavior induced by tEGF,
we measured dynamic signal activation profiles of MSCs on control and tEGF substrata under
the Exp and OS conditions of Figure 1. Our signaling set was comprised of kinases implicated
in literature reports as impacting MSC proliferation or differentiation, with activity level
characterized by specific phosphorylation site status: EGFR (Tyr)4, 5, 7, 28–32, ERK1/2
(Thr202/Tyr204, Thr185/Tyr187)11, 13, 19, 33–37, Akt (Ser473)16, 17, 19, p38 MAPK
(Thr180/Tyr182)13, 22, 23, 38–41, HSP27 (Ser78)42, c-Jun (Ser63)43–45, STAT3 (Ser727)
46, and GSK3α/β (Ser21/Ser9) 20, 21, 25, 47, 48. Signals were measured after 1, 2, 4, 7, and
14 days of culture in either Exp or OS medium in the absence or presence of 1 µM AG1478,
the EGFR kinase inhibitor; all assays consisted of at least biological triplicates. These data are
displayed in Figure 2, enabling visual inspection of the diverse effects of tEGF and culture
media on the various signaling pathway activities. We can identify that 1 µM AG1478
effectively inhibits EGFR phosphorylation with a subsequent effect on ERK 1/2
phosphorylation and a slight reduction in Akt phosphorylation. Akt, c-jun, and Hsp27
phosphorylation signatures were more sensitive to culture medium conditions regardless of the
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presence of the inhibitor. Further, p38 phosphorylation is decreased at day 14 in Exp media
but does not in OS medium. Culture on tEGF affects a number of the kinase activation patterns.
MSC on control surfaces with OS medium have low levels of phosphorylated ERK compared
to those in Exp medium and MSC on tEGF in OS medium at earlier time points, but the OS
treatment values converge by day 7.
The severe challenge of interpreting, solely by intuitive inspection, the relationships of
magnitude and/or timing of signals to phenotypic outcomes is illustrated in Figure 3. This set
of plots show reorganization of the data to indicate whether any clear univariate correlations
(i.e., any particular individual signal in isolation) between signals and phenotypic behavior
might be apparent. We calculated the integral of the activation using the area under the curve
(AUC) for four representative kinase phosphosignals (p-EGFR, p-ERK, p-Akt, p-p38),
capturing the magnitude and duration of the activation (rather than comparing the maximal
value for specific condition or time point). This metric was chosen because differentiation and
proliferation occur over extended time periods, thus integrating over time, effects of signaling
pathway activities that may influence outcomes. These plots illustrate the problem in
attempting to identify monotonic dependences of phenotypic behavior on any individual signal
univariately, as the signal-response relationships are quite complex. In some cases a threshold-
like behavior is suggested for which increase of a particular phosphosignal above a certain
level is associated with a dramatic change in phenotypic behavior. It is conceivable that some
signal-response relationships are more “digital” in nature, with signal levels above or below a
threshold value associated with a particular behavior. With all the signals co-varying, however,
identifying simple dependences of a phenotypic response on any single signal becomes elusive
when a diverse landscape of treatment conditions is considered.
Partial Least-Squares Regression model identifies critical kinase signal combinations
predictive for MSC proliferation and osteogenic differentiation
To construct predictive models that relate quantitative combinations of multiple signals to
phenotypic outcomes across diverse culture conditions, we used partial least squares regression
(PLSR). This computational technique uses linear algebra to reduce the dimensionality of
multi-variate data sets by defining principle component (PC) axes from the original data set
that contain the most important information. Simca-P is the software package we used to
perform the calculations after inputting the normalized and unit scaled data from Figures 1 and
2. PLSR first decomposes multidimensional data into a few PC axes with an algorithm that
captures the maximal variance, and thus, the greatest information. The algorithm uses a
proposed relationship, defined by the user, between the independent (signals; X) and dependent
(responses; Y) variables. The data set is then regressed with a linear solution in principal
component space such that Y=F(X). The variables (kinase signals in this case) exhibiting
strongest covariance contributing most to the dependent variable outputs (proliferation and
differentiation responses here) are weighted more heavily in the solution/prediction function
Y=F(X). In essence, the “noise” of the less important signaling variables and times become
“muted”, and the important signals and metrics become “loud”; this Y=F(X) function that has
now been defined can be used to mathematically predict a response (Y) from the input data
matrix (X), and in doing so, reduce the amount of information necessary for an accurate
prediction.
The ‘scores plot’ in reduced-dimensions (principal component axes) is a graph of the treatments
as the model groups them according to their covariance and projects them onto each PC. The
results are shown in Figure 4. MSCs cultured in OS medium are seen to separate along PC 1
from those in Exp medium, and PC 2 separates MSCs on tEGF from those on control surfaces
(Fig 4A). Interestingly, MSCs cultured on tEGF and treated with AG1478, are grouped closer
to control than their tEGF uninhibited counterparts; the model has done this based solely on
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the kinase signatures measured over these time points without specifying external knowledge
concerning any particular effects (such as “AG” being an inhibitor of EGFR kinase activity)
(Fig 4A). In Figure 4B, the responses of proliferation (21 day cell number) and differentiation
(21 day Alizarin Red) are separated along PC 1. Taken together, the first PC can be defined as
the osteogenic differentiation vs. proliferation axis and the second PC as the tEGF influence
axis (Fig 4C). It can be inferred that tEGF contributes more to osteogenic differentiation (here,
21 day Alizarin Red) than cell number (21 day cell number) by comparing the magnitude
(i.e., perpendicular length) of the response vector projections onto PC 2 (Fig 4C); 21 day
Alizarin Red is almost three times the perpendicular length from the x-axis than 21 day cell
number.
Kinase signals organize toward a phenotypic response by day 7
The ‘loadings plot’ summarizes the corresponding influence that each signal has on a response,
in context of all the other signal effects, represented by the weight it is given in the calculation/
prediction function Y=F(X) where Y and X are M × N matrices spanning the time points and
kinase signals measured. Mapping the loadings in Figure 5 provides a visual representation of
their contribution to the two responses, enabling tracking of the kinase signals with respect to
cell fate decision processes over time. Total kinase levels in PC space cluster with cell
proliferation at day 4 (green, Supplementary Fig 2), but contribute more to the 21 day OS
differentiation response by day 7 (black, Supplementary Fig 2). Interestingly, kinase
phosphosite contributions are widely dispersed throughout the PC space at day 4 (Fig 5A). By
day 7, however, phosphorylation levels have clearly polarized to osteogenic differentiation or
proliferation outcomes (Fig 5B) as judged by their close proximity on the loadings plot in PC
space. GSK3α/β either seems to contribute equally to both, or not significantly involved with
the responses measured.
New PLSR models were constructed relating each of the signal time-points (i.e., day 4, day 7,
or day 14) to day 21 cell responses of proliferation and matrix mineralization, in order to
evaluate their respective predictive capabilities. A model was exclusively trained with only
day 4, or day 7, or day 14 signals to calculate day 21 responses. Prediction ability was
determined using the weights assigned to each kinase in the particularly associated new
function Y=F(X), to calculate and predict day 21 values; those predictions were then compared
with actual observed values. 100% predictability would mean the calculated values across all
treatment conditions would be the same as observed values across all treatment conditions. As
shown in Figure 5C, each of the time-points provides kinase signal combinations that are
reasonably predictive of the day 21 phenotypic outcomes. Interestingly, the strongest predictive
capability is achieved by the day 7 signals. This result implies: [a] that execution of proliferation
and differentiation behavior is governed by a quantitative combination of kinase signals across
the full set of culture conditions; and [b] that the time-frame for this governance to be
manifested (presumably by ensuing gene expression and feedback to the regulatory pathways
internally and externally) is on the order of at least a week or two – i.e., the difference between
day 21 outcomes and day 7 signals.
Identification of the most important kinase signals reduces the amount of data required to
accurately predict MSC responses
Development of this data-driven model required a large number of signaling measurements:
~1060 measurements of 8 kinases, 2 ligands, and 7-day alkaline phosphatase activity, across
8 treatment conditions with at least 7 different assays and up to 5 time points. Along with the
predictive modeling capability itself, PLSR analysis also can identify the most important
signals for a cellular outcome by calculating the variable importance for projection (VIP) using
a weighted sum of squares, such that signals projecting strongly either positively or negatively
with a response are highly ranked. In Table 1, we show that the top 7 VIPs, and 12 out of the
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top 20, are from day 7 determined by a model trained with our entire data set of vehicle and
inhibitor data over 14 days, matched to 21 day response of matrix mineralization. To ease the
effort and cost of a 21 day experiment, collection of kinase signals at one relatively early, highly
predictive time point would be beneficial; a prime time point is 7 days especially since it also
provided the greatest predictability of 21 day outputs when the model is trained with only a
single day’s input (Fig. 5C).
To facilitate experimental simplification and cost reduction, we limited the model training set
to only Novagen and Bioplex assays at day 7, becoming a two lysate-four assay condition, and
were able to retain 99% predictability of 21-day matrix mineralization. Even further reduction
to a one lysate-two assay condition with only the phosphosites for EGFR, Akt, ERK 1/2, Hsp27,
c-jun, GSK3α/β, p38 MAPK, and STAT3 at day 7 retained 93% predictability of 21 day matrix
mineralization by MSCs cultured in osteogenic media on control or tEGF surfaces
(Supplementary Table 1).
A priori prediction of the combined effects on 21 day OS differentiation and matrix
mineralization of tEGF and collagen
To determine whether our reduced model could be used to make a priori predictions of MSC
differentiation under untested, microenvironmental changes, MSCs were seeded on type I
collagen coated polymeric scaffolds with or without tethered EGF and cultured for 7 days. It
is known that integrin engagement of extracellular matrix proteins activates intracellular
signaling cascades that control cell behavior, and collagen, specifically, has been shown to
contribute to the differentiation of MSCs and other pre-osteoblastic cell types18, 50, 51.
However, it remains uncertain how signals downstream of integrins and growth factor receptors
are quantitatively integrated to corporately regulate phenotypic behavior. We chose to test two
hypotheses with our model: first, if collection of only 7 day kinase phosphorylation signals
would be predictive of the 21 day mineralization of MSCs on type I collagen; and second, if
there is a synergistic effect between tEGF and collagen on increasing MSC osteogenic
differentiation and matrix mineralization. The results are shown in Figure 6.
To generate a new and independent experimental data-set for direct test of PLSR model
predictions corresponding to these hypotheses, surfaces were prepared as previously except
that 1 µg/ml of type I collagen was adsorbed at room temperature for one hour prior to cell
seeding. After 24 hours, medium was changed to OS and changed every third day. On day 7,
samples were collected, total protein determined, and phosphorylation was determined as
above. Phase images of the cells on the different surfaces at day 7 are shown (Fig. 6A). The
profiles of the measured kinase phosphorylation signals differ between the collagen coated
surfaces and the no ECM controls (Fig 6B). These newly-generated day 7 phosphosite
measurements were inserted into the PLSR model originally constructed from the earlier data-
set, and weighted coefficients were mathematically determined according to the NIPALS
algorithm as described above for the full data set. Simca-P algorithms then calculated
phenotypic outcomes (scaled between 0 and 1) for 21-day matrix mineralization, and the
predicted control (no ECM) responses matched previously observed 21-day matrix
mineralization results where tEGF caused a two-fold increase over control. On control,
uncoated surfaces without tEGF, the model predicted that type I collagen would increase matrix
mineralization. However, it predicted that the combination of type I collagen and tEGF would
reduce the 21-day matrix mineralization from that of just tEGF, not enhance it (Fig 6C).
To test this result experimentally, MSCs were seeded, cultured for 21 days, fixed, stained with
Alizarin Red S, imaged, and quantified as above. These results successfully realized the model
predictions: on control surfaces coated with type I collagen, MSCs created more mineralized
matrix than the matching no-ECM controls, and the synergy of tEGF and collagen reduced
matrix mineralization from that of tEGF alone (Fig 6D). More importantly, this result verified
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that collection of 7-day kinase signatures were predictive of 21-day mineralization of MSCs
under different conditions using our computational model developed with partial least squares
regression.
DISCUSSION
MSCs have been proposed in tissue engineering to regenerate bone. However, early attempts
have been stymied by both low numbers of MSCs and the death of these cells when implanted
in vivo. Recently we reported that MSCs can be expanded ex vivo by EGF, and that EGF, when
presented in a tethered manner, protects these cells from death7,8. This led to the finding that
culturing MSCs on tethered EGF enhances the osteoinductive properties of osteogenic stimuli
via sustained EGFR phosphorylation10, offering a new biomaterials-oriented approach to
enhancing osteogenic differentiation. However, it was not evident whether this arose from
greater activity per cell or augmented number of surviving MSCs, or both. Thus we sought to
enhance this approach by means of additional growth factors, extracellular matrix adhesion
ligands, and/or small molecule pathway modulators. However, rational usage of multiple cues
requires increased understanding of their signaling pathway activation to regulate phenotypic
behavior52, 53. For regulation of embryonic stem cell self-renewal and differentiation54 as well
as a spectrum of other cell fate decisions55–59, individual signaling pathways are not
univariately predictive of responses to extracellular stimuli nor are input cues simply additive
or even synergistic; instead, rational prediction of cell fate outcomes across diverse treatment
conditions requires determination of how multiple pathways are quantitatively combined into
a ‘network state’ that integratively governs response. We apply this approach here to gain
predictive understanding of MSC osteogenic differentiation in response to different
biomaterials culture conditions, including tethered EGF in presence or absence of collagen-I.
For the foundational study of MSCs cultured on tEGF versus control substrata (and +/− an
EGFR inhibitor), Figure 2 shows the time-courses of measured signal phosphosites: p-EGFR,
p-ERK1/2, p-Akt, p-p38, p-HSP27, p-c-Jun, p-STAT3, and p-GSK3α/β. Figure 3 illustrates
that none of these signals are strongly correlated with cell proliferation or differentiation
outcomes across all culture conditions. In contrast, Figure 5C shows that a computational model
using partial least-squares regression ascertains quantitatively weighted combinations of these
signal phosphosites capable of predicting osteogenic differentiation behavior across these
culture conditions, and Figure 5B locates the qualitative and quantitative contributions of the
various signals to the model: p-EGFR, p-Akt, and p-HSP27 are found strongly positively
associated with mineralization activity while p-ERK is found strongly negatively associated;
p-p38 contributes mildly in positive manner whereas p-c-jun contributes mildly in negative
manner.
We then proceeded to test this predictive model capability for its utility in understanding the
effects of culture on type I collagen, a major structural protein of bone and produced during
osteogenic differentiation. Bone progenitor cells lay down collagen prior to matrix
mineralization60, 61 and most likely do so on our polymer surfaces whether EGF is tethered or
not. The ultimate goal is to use this material for clinical bone grafts to be seeded with a patient’s
own bone marrow progenitor cells, and coating these surfaces with matrix proteins preferred
by the cells is an attractive method for enhancing desired MSC behavior. This was not the case
with collagen I, however. It did increase MSC osteogenic differentiation with no tEGF (Fig
6D) as has been reported62–64, but MSC engagement of EGFR with tEGF and integrin binding
to collagen I actually mitigated the differentiation response induced by tEGF alone (Fig 6C,
D). Reports have shown that soluble EGF decreases collagen I synthesis30 but the converse
has not been shown. Figure 6C shows the integrated effects of the growth factor and
extracellular matrix ligands on the kinase signaling network activities and that our PLSR model
comprehends all these effects. It successfully predicted, in a completely a priori manner,
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osteogenic differentiation under a new, independent set of culture conditions involving
substrate coated with collagen-I in presence or absence of tEGF. The effects of this materials-
based outcome could not be obviously anticipated, for as shown in Figure 6B the influence of
collagen-I on the various kinase signals is quite diverse rendering prediction of consequent
phenotypic effects difficult.
The kinase signals chosen for this study are generally appreciated to serve as major integrators
of disparate canonical pathways. Kinase phosphorylation is transient due to the dynamic
interplay between kinases and phosphatases. It may at first glance seem somewhat surprising
that transient tools used by cells to transduce extracellular information would be able to predict
phenotypic behavior a week or more later, as is demonstrated in Figure 5C. However, upon
reflection it is realized (as illustrated in Figure 7A) that signaling network activities at a given
point in time lead to alterations in gene expression (as well as metabolic and cytoskeletal
processes) that ultimately execute observable phenotypic behavior, or metaphorically, resets
the keyboard upon which the subsequent song is played. Along the way, the signaling network
is modulated further by feedback from alterations in gene expression that operate both
intracellularly and extracellularly. An intriguing question associated with this understanding
is what the time-frame containing the most informative network signaling measurements might
be. Figure 7B illustrates this conceptually for the day-21 differentiation outcome studied in
this present work. Network activity at an intermediate time-point might be most informative
due to a temporal balance between fate decision and effector actions; the earliest time-points
may be less informative because more uncertainty exists concerning the evolution of the gene
expression-related feedback loops, and the latest time-points may be less informative because
the cell fate decision is largely determined before all the ensuing processes are completely
played out. Figure 5C shows the actual result of our combined experimental/computational
study, with day-7 network activity being most informative for prediction of day-21 phenotype.
Nonetheless, it is not the case that day 7 is a “lucky guess” or “magic window” because Figure
5C also shows that day-4 and day-14 signals are also at least reasonably effective in the day-21
outcome prediction. Interestingly, a previous study of a different cell phenotypic fate decision
– apoptotic cell death – similarly found that maximal predictive capability of signaling network
information was obtained within an intermediate time-frame65.
As MSCs differentiate into osteoprogenitors and osteoblasts, timed activation and inactivation
of histone acetylases and deacetylases, transcription factors, extracellular matrix production,
and osteoblast-specific enzymatic activity are regulated by signals intra- and extra-cellularly
as well as intra- and extra-nuclearly; Runx2, TGF-β, Wnt, and osteopontin along with collagen
I being among the most intensely studied. Reviews of these interactions and feedback/feed-
forward loops have highlighted important findings identifying contributions of various
components and pathways during periods of MSC proliferation, maturation, and matrix
mineralization60, 66–70. We note here the timing of peaks of maximal mRNA expression of
collagen I and alkaline phosphatase (early and mid) compared to osteocalcin and collagenase
(late)66 represents transcriptional processes preparing for the next phase of differentiation,
supporting our Figure 7 schematic that potentially explains our finding that day 7 kinase signals
are more predictive than day 14 signals for day 21 mineralization. Absent intervening
perturbations, our results are consistent with gene expression literature on chronological
programming of differentiation from extracellular cues to signaling activities to gene
expression, with feedback loops at both extracellular and intracellular aspects of the regulatory
process.
This study highlights more than the particular pattern of signal-response relationships for this
focused cell culture study. It is quite plausible that assessment of a comparable though
alternatively specified set of signaling network nodes could produce a similarly predictive
model for longer-term osteogenesis. Such a model enabling prediction of cell fate outcomes
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from a dynamic network signature could perhaps be utilized for more deeply informative
testing combinations of cues (materials, growth factors, extracellular matrix, and/or small
molecules), permitting increased effectiveness in translation between ex vivo and in vivo
outcomes by means of the multi-variate signal-response model relationships74.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Proliferation and differentiation are divergent outcomes for MSCs cultured in the
presence of osteoinductive supplements
(A) After 21 days, MSCs were cultured on control or tEGF surfaces for 21 days in osteogenic
media in the presence or absence of 1 uM AG1478, then stained with Alizarin Red. Images
were captured and quantified (*p<.01, n=3 compared to tEGF vehicle). The result shown is
from one representative experiment with n=6, from Reference 10. (B) Human primary MSCs
were cultured on control surfaces or on tethered EGF surfaces in expansion (Exp) medium or
osteogenic (OS) differentiating media for 2, 4, 7, 14, and 21 days and prepared according to
CyQuant protocols. Cell number was calculated by fitting the fluorescence to a standard curve
prepared with known cell numbers from a trypsinized plate of MSCs.
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Figure 2. Kinase signal collection of time dependent changes during osteogenic differentiation
Human primary MSCs were seeded onto control or tEGF surfaces in Exp medium, then
changed to OS or fresh Exp in the presence or absence of 1 µM AG1478, an EGFR kinase
inhibitor, for 1, 2, 4, 7, or 14 days followed by cell lysis. Total protein was determined, and
equal amounts were loaded for Bioplex or Novagen bead-based immunoprecipitation assays
to detect phosphorylation or total protein amounts of the kinases listed. Fluorescence values
were normalized to a master lysate and then to the maximum value for each signal to scale the
values between 0 and 1. MSC kinase signals data are plotted over 14 days comparing control
(black) and tEGF (red) surfaces in Exp (open, dashed line) or OS (closed, solid line) in the
absence (squares) or presence (triangles) of 1µM AG1478. Each data point represents the mean
of 3–6 biological replicates.
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Figure 3. Univariate approaches to analyzing multi-pathway data sets do not fully appreciate the
interconnectedness of the signaling networks involved in MSC differentiation and proliferation
Areas under the curve of kinase phosphorylation were calculated for ERK1/2, EGFR, Akt, and
p38 MAPK over the 4–14 day period, and plotted on the X-axis with 21-day cell count (A) or
21 day matrix mineralization (B) or on the Y-axis, for four different treatment conditions in
each case. Lines connecting data points are provided as eye-guides to aid the reader in
discerning possible trends or lack thereof for the phenotypic responses with respect to the
various individual phosphosignals.
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Figure 4. Treatment conditions are successfully separated by a partial least squares regression
model trained with kinase signaling dynamics
(A) Treatment conditions are separated by the model in the scores plot, and the EGFR inhibitor
on tEGF kinase signals clusters these treatments with control conditions. (B) Loadings (weight
coefficients) of the two responses are separated along the first principle component. (C) Based
on the response loadings, the first two PC axes can be defined as 1) proliferation vs.
differentiation and 2) tEGF influence.
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Figure 5. Treatment conditions are successfully separated by a partial least squares regression
model trained with kinase signaling dynamics
(A) This plot exhibits the loadings of the phosphorylation of each measured kinase at day 4
and their broad distribution whereas by day 7, (B) the signals cluster with either the proliferation
response (c-jun, ERK, STAT3) or the differentiation response (EGFR, Akt, Hsp27, p38).
(C) A new model was trained with all signals, or only single day 4, 7, and 14 signals, and
predictability for 21-day differentiation were calculated. Predictability was greatest for day 7.
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Figure 6. Minimal kinase signaling measurements at day 7 predict, a priori, the synergistic effects
of collagen and tEGF on 21-day matrix mineralization
(A) Phase images under 10X objective of MSCs after 7 days of culture on control or tEGF
surfaces preadsorbed with collagen or no ECM control. (B)Lysates were collected after 7 days
of culture in OS medium on control or tEGF surfaces with or without 1 µg/ml type I collagen,
and phosphorylation was determined with Bioplex assays.Arrows underneath each kinase
graph are symbolic of each kinase VIP (larger arrows have greater VIPs than smaller arrows:
up arrows indicate that phosphorylation of the kinase correlated with promoting OS
differentiation, and down arrows correlated with increased cell number and not OS
differentiation as determined from the PLSR model. (C) Using only these inputs, the model
predicted an increase in mineralization on control surfaces in the presence of collagen I, but a
decrease in mineralization on both tEGF and collagen I. (D) Human primary MSCs were
cultured on control or tEGF surfaces for 21 days in osteogenic media with or without 1 µg/ml
type I collagen preadsorbed onto the surfaces, then stained with Alizarin Red and quantified.
Observations match the model predictions (n=3, *p<.05, #p<.01; p=.06 for control no ECM
compared to control collagen I).
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Figure 7. Minimal kinase signaling measurements at day 7 predict, a priori, the synergistic effects
of collagen and tEGF on 21-day matrix mineralization
(A) Schematic diagram of conclusions. Growth factors and extracellular matrix influence
kinase activity and gene expression of MSCs. The gene expression and subsequent activities
of the MSCs further modify the extracellular matrix and growth factors of the environment as
they differentiate which all affect the differentiation status of the cells. (B) Maximal predictions
from PLSR model occur at intermediate time (day 7) as there is a time lag for downstream
effects of differentiation.
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